Usefulness of CHROMagar Candida Medium, biochemical methods - API ID32C and VITEK 2 compact and two MALDI-TOF MS systems for Candida spp. identification

• Autorzy: Stefaniuk E. , Baraniak A. , Fortuna M. , Hryniewicz W.
• Języki publikacji: EN

Abstrakty

EN

This study was conducted to compare of the yeasts identification results obtained with two new systems using the MALDI-TOF MS technique with the ones obtained using the routine identification methods of Candida spp. in clinical microbiology laboratories. All 124 Candida spp. isolates were recovered from the routine examination of clinical specimens in microbiological laboratories and collected in the Centre of Quality Control in Microbiology in Warsaw (Poland). Our findings confirm the high agreement (98%) of fungal identification using the standard, biochemistry laboratory methods and mass spectrometry technique.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2016
• Tom: 65
• Numer: 1
• Opis fizyczny: p.111-114,ref.

Twórcy

autor

Stefaniuk E.

• Centre of Quality Control in Microbiology, Warsaw, Poland
• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

autor

Baraniak A.

• Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland

autor

Fortuna M.

• Centre of Quality Control in Microbiology, Warsaw, Poland

autor

Hryniewicz W.

• Centre of Quality Control in Microbiology, Warsaw, Poland
• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

Bibliografia

• Basssetti M., F. Ansaldi, L. Nicilini, E. Malfatto, M.P. Molinari, M. Mussap, B. Rebesco, F. Bobio Pallavicini, G. Icardi and C. Viscoli. 2009. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J. Antimicrob. Chemother. 64: 625–629.
• Bassetti M., E. Righi, A. Costa, R. Fasce, M.P. Molinari, R. Rosso, F.B. Pallavicini and C. Viscoli. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6: 21.
• Campanha N.H., K.H. Neppelenbroek, D.M.P. Spolidorio, L.C. Spolidorio and A.C. Pavarina. 2005. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis. 11: 392–398.
• Clark R.B., M.A. Lewinski, M.J. Loeffenlholz and R.J. Tibbetts. 2009. Cumitech 31A. Verification and Validation of Procedures in the Clinical Microbiology Laboratory, ed. Sharp S.E. ASM Press, Washington, D.C.
• Freydiere A.M., R. Guinet and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39: 9–33.
• Graf B., T. Adam, E. Zill and U.B. Göbel. 2000. Evaluation of the VITEK 2 System for rapid identification of yeast-like organisms.J. Clin. Micriobiol. 38: 1782–1785.
• Kirkpatrick W.R., G.R. Sanjay, R.K. McAtee, J.L. Lopez-Ribot, A.W. Fothergill, D.I. McCarthy, S.E. Sanche, R.A. Cantu,M.G. Rinaldi and T.F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36: 3007–3012.
• Levy I., L.G. Rubin, S. Vasishtha, V. Tucci and S.K. Sood. 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin. Infect. Dis. 26: 1086–1088.
• Marklein G., M. Josten, U. Klanke, E. Müller, R. Horré and T. Maier. 2009. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47: 2912–2917.
• Martinez L., J.L. López-Ribot, W.R. Kirkpatrick. B.J. Coco,S.P. Bachmann and T.F. Patterson. 2002. Replacement of Candida albicans with Candida dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal. J. Clin. Microbiol. 40: 3135–3139
• Martinez-Lamas L., M.L. Perez del Molino, F. Pardo, E. Varela and B.J. Regueiro. 2011. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans. Enfermedades Infecciosa y Microbiologia Clinica. 29: 568–572.
• Pravin C.M.V., A. Kali. and N.M. Joseph. 2015. Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials. Pharmacognosy Research. 7(Suppl 1): S69–S73.
• Prod’hom A., C. Bizzini, J. Durussel, G. Bille and G. Greub. 2010. Matrix assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J. Clin. Microbiol. 48: 1481–1483.
• Pulcrano G., D.V. Iula, A. Vollaro, A. Tucci, M. Cerullo, M. Esposito, F. Rossano and M.R. Catania. 2013. Rapid and reliable MALDI-TOF mass spectrometry identification Candida non-albicans isolates from bloodstream infections. J. Microbiol. Methods. 94: 262–266.
• Ruhnke M., A. Schmidt-Westhausen and J. Morschhauser. 2000. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J. Antimicrob. Chemother. 46: 291–295
• Raut S.H. and A. Varaiya. 2009. Differentiation of Candida dubliniensis on chrom agar and Pal’s agar. Indian J. Med. Microbiol. 27: 55–58.
• Sow D., B. Fall, M. Ndiaye, B.S. Ba, K. Sylla, R. Tine, A.C. Lô,A. Abiola, B. Wade, T. Dieng and others. 2015. Usefulness of MALDI-TOF mass spectrometry for routine identification of Candida species in a resource-poor setting. Mycopathologia 180: 173–179.
• Sullivan D. and D. Coleman. 1998. Candida dubliniensis: Characteristics and identification. J. Clin. Microbiol. 36:329–334.
• Van Veen S.Q., E.C. Claas and E.J. Kuijper. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization time-of-flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48: 900–907.

Identyfikatory

DOI

10.5604/17331331.1197283